mdh006

Mark Hurwitz, MD, FACRO, FASTRO

Contact Dr. Hurwitz

111 South 11th Street
Bodine Cancer Center,
Suite G-301
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
  2. A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer
  3. Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer
  4. A Pilot Study of Radiation Therapy in Combination with Pembrolizumab in Patients with Metastatic Renal Cell Cancer
  5. Application of Forcing Functions to Electronic Health Records Is Associated With Improved Pain Control for Patients Undergoing Radiation Therapy for Bone Metastases
  6. ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy with Radium-223
  7. Hyperthermia and immunotherapy: clinical opportunities
  8. Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy
  9. The docetaxel debate: Impact of chemotherapy in high-risk non-metastatic prostate cancer
  10. Quality assurance guidelines for interstitial hyperthermia
  11. Cancer of the urethra and penis
  12. Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer
  13. Dual Modality Implant for Simultaneous Magnetic Nanoparticle Heating and Brachytherapy Treatment of Tumor Resection Cavities in Brain
  14. Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy
  15. Chemotherapy and radiation for prostate cancer
  16. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  17. Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
  18. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621
  19. Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements
  20. Quality assurance guidelines for superficial hyperthermia clinical trials: II. Technical requirements for heating devices | Leitlinien zur Qualitätssicherung der lokalen Hyperthermie in klinischen Studien: II. Technische Anforderungen an Heizgeräte